ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma-Reference-Cited by-同舟云学术

ERBB2-CAR-Engineered Cytokine-Induced Killer Cells Exhibit Both CAR-Mediated and Innate Immunity Against High-Risk Rhabdomyosarcoma

Published:2020-10-19 Issue: Volume:11 Page:
ISSN:1664-3224
Container-title:Frontiers in Immunology
language:
Short-container-title:Front. Immunol.

Author:

Merker Michael,Wagner Juliane,Kreyenberg Hermann,Heim Catrin,Moser Laura M.,Wels Winfried S.,Bonig Halvard,Ivics Zoltán,Ullrich Evelyn,Klingebiel Thomas,Bader Peter,Rettinger Eva

Publisher

Frontiers Media SA

Subject

Immunology,Immunology and Allergy

Reference55 articles.

1. Oncology meets immunology: the cancer-immunity cycle;Chen;Immunity.,2013

2. Intensive multiagent therapy, including dose-compressed cycles of Ifosfamide/Etoposide and Vincristine/Doxorubicin/Cyclophosphamide, irinotecan, and radiation, in patients with high-risk rhabdomyosarcoma: a report from the children's oncology group;Weigel;J Clin Oncol.,2016

3. Haploidentical allogeneic hematopoietic stem cell transplantation in patients with high-risk soft tissue sarcomas: results of a single-center prospective trial;Merker;Bone Marrow Transplant.,2018

4. Cancer-cell-intrinsic mechanisms shaping the tumor immune landscape;Wellenstein;Immunity.,2018

5. Adoptive cellular immunotherapy for refractory childhood cancers: a single center experience;Merker;Oncotarget.,2019

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Targeted immunotherapy and nanomedicine for rhabdomyosarcoma: The way of the future;Medicinal Research Reviews;2024-06-17

2. CAR Cells beyond Classical CAR T Cells: Functional Properties and Prospects of Application;Biochemistry (Moscow);2024-05

3. CAR products from novel sources: a new avenue for the breakthrough in cancer immunotherapy;Frontiers in Immunology;2024-04-11

4. Contemporary preclinical mouse models for pediatric rhabdomyosarcoma: from bedside to bench to bedside;Frontiers in Oncology;2024-02-02

5. CAR NK Cell Therapy for the Treatment of Metastatic Melanoma: Potential & Prospects;Cells;2023-11-30